Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients
Launched by UNIVERSITY OF SAO PAULO · Jun 2, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how exercise might help doctors understand the health of adults who have flu-like symptoms, especially focusing on those who have not been vaccinated. Researchers want to see if a specific test, called an ergometric test, which measures how the heart and blood pressure respond during exercise, can provide useful information about a patient's health. The study will follow participants for 30 days to assess their progress.
To be eligible for this trial, participants should be adults aged 65 to 74 who are experiencing flu-like symptoms. However, those who have recently had orthopedic surgery will not be able to join. If you participate, you will be asked about your vaccination history and undergo the ergometric test, where doctors will observe how long you can exercise and check for any heart-related issues during the test. This research aims to improve how doctors predict and manage the health of patients with flu-like symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • flu-symptoms
- Exclusion Criteria:
- • recent orthopedic surgery
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, Sp, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported